Skip to content

Insider · CIK 0001031689

Simon H Stertzer

director

Files at BCDA (BioCardia, Inc.). First filing Mar 5, 2025, latest Jun 24, 2026.

Simon H Stertzer files SEC Form 4 as director at BCDA (BioCardia, Inc.). Since Mar 5, 2025, Simon H Stertzer has reported 6 open-market buys worth $1.0M and 0 open-market sells worth $0, the latest filed on Jun 24, 2026.

A track record needs three past buys with six months of prices behind them; Simon H Stertzer has 0, so none is measured yet.

The newest scored trade: bought $104k of BCDA on Jun 22, 2026, filed Jun 24, 2026, scored 51 (moderate). In the last 12 months: 1 buy worth $104k and 0 sells worth $0.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
6 / 0
$1.0M bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

BCDA: BioCardia, Inc.

BCDAOct 9, 2026 · close 1.04

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
51Moderate
BCDAbuy 2
BioCardia, Inc.
$104k
109,200 shares
+191%+21% from low-60% from high
81Strong
BCDAbuy 3
BioCardia, Inc.
$498k
398,400 shares
+207%0% from low-63% from high
64Notable
BCDAbuy 4
BioCardia, Inc.
$150k
72,289 shares
+60%+11% from low-38% from high
75Notable
BCDAbuy 6
BioCardia, Inc.
$200k
104,986 shares
+683%+6% from low-40% from high
32Weak
BCDAbuy 2
BioCardia, Inc.
$2,450
1,000 shares
+2%+38% from low-19% from high
46Moderate
BCDAbuy 2
BioCardia, Inc.
$88k
38,289 shares
+215%+39% from low-18% from high

Transactions

Every row this insider has filed, 13 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 22, 2026BCDA
BioCardia, Inc.
POpen-market purchase
Common Stock
+70,200$0.92$65k127,338Jun 24, 2026
Jun 23, 2026BCDA
BioCardia, Inc.
POpen-market purchase
Common Stock
+39,000$1.00$39k166,338Jun 24, 2026
Dec 8, 2025BCDA
BioCardia, Inc.
AGrant or award
Stock Option (right to buy)derivative
+12,000$0.00$015,573Dec 10, 2025
Sep 19, 2025BCDA
BioCardia, Inc.
POpen-market purchase
Common Stockindirect: See Footnote
+398,400$1.25$498k591,054Sep 23, 2025
Sep 19, 2025BCDA
BioCardia, Inc.
POpen-market purchase
Warrant (right to buy)derivativeindirect: See Footnote
+398,400--575,675Sep 23, 2025
Jun 30, 2025BCDA
BioCardia, Inc.
POpen-market purchase
Common Stockindirect: See Footnote
+72,289$2.08$150k192,654Jul 2, 2025
Jun 30, 2025BCDA
BioCardia, Inc.
POpen-market purchase
Warrant (right to buy)derivativeindirect: See Footnote
+72,289--177,275Jul 2, 2025
Apr 23, 2025BCDA
BioCardia, Inc.
POpen-market purchase
Common Stockindirect: See Footnote
+104,986$1.91$200k120,365Apr 25, 2025
Apr 23, 2025BCDA
BioCardia, Inc.
POpen-market purchase
Warrant (right to buy)derivativeindirect: See note
+104,986--104,986Apr 25, 2025
Mar 5, 2025BCDA
BioCardia, Inc.
POpen-market purchase
Common Stock
+1,000$2.45$2,45057,138Mar 7, 2025
Mar 3, 2025BCDA
BioCardia, Inc.
POpen-market purchase
Common Stock
+22,753$2.30$52k40,602Mar 5, 2025
Mar 4, 2025BCDA
BioCardia, Inc.
POpen-market purchase
Common Stock
+15,536$2.30$36k56,138Mar 5, 2025
Oct 11, 2024BCDA
BioCardia, Inc.
AGrant or award
Stock Option (right to buy)derivative
+829$0.00$03,573Oct 16, 2024

Questions about Simon H Stertzer

Answered from the filings on this page, as of the latest one.

Is Simon H Stertzer buying or selling?

In the last 12 months Simon H Stertzer reported 1 open-market buy worth $104k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $104k of BCDA on Jun 22, 2026. Grants, option exercises and tax withholding are not counted.

How did Simon H Stertzer's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Simon H Stertzer has 0.

Where does Simon H Stertzer file Form 4?

Simon H Stertzer has filed Form 4 at BCDA (BioCardia, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.